Logo image of ALENO.PA

ENOGIA SAS (ALENO.PA) Stock Fundamental Analysis

EPA:ALENO - Euronext Paris - Matif - FR0014004974 - Common Stock - Currency: EUR

2.4  -0.09 (-3.61%)

Fundamental Rating

2

Overall ALENO gets a fundamental rating of 2 out of 10. We evaluated ALENO against 60 industry peers in the Electrical Equipment industry. ALENO has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALENO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALENO has reported negative net income.
In the past year ALENO has reported a negative cash flow from operations.
ALENO had negative earnings in each of the past 5 years.
In the past 5 years ALENO always reported negative operating cash flow.
ALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFALENO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

ALENO's Return On Assets of -12.57% is on the low side compared to the rest of the industry. ALENO is outperformed by 73.33% of its industry peers.
ALENO's Return On Equity of -33.86% is on the low side compared to the rest of the industry. ALENO is outperformed by 76.67% of its industry peers.
Industry RankSector Rank
ROA -12.57%
ROE -33.86%
ROIC N/A
ROA(3y)-18.98%
ROA(5y)-16.58%
ROE(3y)-48.72%
ROE(5y)-109.12%
ROIC(3y)N/A
ROIC(5y)N/A
ALENO.PA Yearly ROA, ROE, ROICALENO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 81.65%, ALENO belongs to the top of the industry, outperforming 98.33% of the companies in the same industry.
In the last couple of years the Gross Margin of ALENO has declined.
The Profit Margin and Operating Margin are not available for ALENO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.95%
GM growth 5YN/A
ALENO.PA Yearly Profit, Operating, Gross MarginsALENO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

ALENO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALENO has been increased compared to 1 year ago.
ALENO has a better debt/assets ratio than last year.
ALENO.PA Yearly Shares OutstandingALENO.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2M 4M 6M
ALENO.PA Yearly Total Debt VS Total AssetsALENO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that ALENO is in the distress zone and has some risk of bankruptcy.
ALENO has a Altman-Z score of 0.50. This is in the lower half of the industry: ALENO underperforms 68.33% of its industry peers.
A Debt/Equity ratio of 0.79 indicates that ALENO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.79, ALENO is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC7.1%
ALENO.PA Yearly LT Debt VS Equity VS FCFALENO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M

2.3 Liquidity

ALENO has a Current Ratio of 1.33. This is a normal value and indicates that ALENO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALENO (1.33) is comparable to the rest of the industry.
A Quick Ratio of 1.27 indicates that ALENO should not have too much problems paying its short term obligations.
ALENO has a Quick ratio of 1.27. This is in the better half of the industry: ALENO outperforms 71.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.27
ALENO.PA Yearly Current Assets VS Current LiabilitesALENO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

5

3. Growth

3.1 Past

ALENO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.39%, which is quite impressive.
ALENO shows a strong growth in Revenue. In the last year, the Revenue has grown by 53.94%.
ALENO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.71% yearly.
EPS 1Y (TTM)58.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.16%
Revenue 1Y (TTM)53.94%
Revenue growth 3Y37.71%
Revenue growth 5YN/A
Sales Q2Q%53.15%

3.2 Future

The Earnings Per Share is expected to grow by 47.36% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y80%
EPS Next 2Y41.42%
EPS Next 3Y47.36%
EPS Next 5YN/A
Revenue Next Year60%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALENO.PA Yearly Revenue VS EstimatesALENO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M
ALENO.PA Yearly EPS VS EstimatesALENO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALENO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALENO.PA Price Earnings VS Forward Price EarningsALENO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALENO.PA Per share dataALENO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

ALENO's earnings are expected to grow with 47.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y47.36%

More info and screens

0

5. Dividend

5.1 Amount

ALENO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENOGIA SAS

EPA:ALENO (3/7/2025, 7:00:00 PM)

2.4

-0.09 (-3.61%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.49%
Inst Owner ChangeN/A
Ins Owners26.37%
Ins Owner ChangeN/A
Market Cap15.10M
Analysts86.67
Price Target3.26 (35.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.98
P/FCF N/A
P/OCF N/A
P/B 2.08
P/tB 22.17
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-1.03
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS0.81
BVpS1.16
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.57%
ROE -33.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.65%
FCFM N/A
ROA(3y)-18.98%
ROA(5y)-16.58%
ROE(3y)-48.72%
ROE(5y)-109.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.95%
GM growth 5YN/A
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 137.84%
Cap/Sales 46.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.27
Altman-Z 0.5
F-Score4
WACC7.1%
ROIC/WACCN/A
Cap/Depr(3y)160.07%
Cap/Depr(5y)156.1%
Cap/Sales(3y)48.6%
Cap/Sales(5y)47.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.16%
EPS Next Y80%
EPS Next 2Y41.42%
EPS Next 3Y47.36%
EPS Next 5YN/A
Revenue 1Y (TTM)53.94%
Revenue growth 3Y37.71%
Revenue growth 5YN/A
Sales Q2Q%53.15%
Revenue Next Year60%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.52%
OCF growth 3YN/A
OCF growth 5YN/A